Published in Cell Mol Life Sci on May 01, 2002
Proangiogenic role of neutrophil-like inflammatory heterophils during neovascularization induced by growth factors and human tumor cells. Blood (2005) 1.17
Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization. Diabetes (2011) 1.11
Cyclooxygenases and lipoxygenases in cancer. Cancer Metastasis Rev (2011) 1.04
Differential expression of thromboxane synthase in prostate carcinoma: role in tumor cell motility. Am J Pathol (2004) 1.00
Nucleolin regulates c-Jun/Sp1-dependent transcriptional activation of cPLA2alpha in phorbol ester-treated non-small cell lung cancer A549 cells. Nucleic Acids Res (2007) 0.93
The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis. Cancer Metastasis Rev (2011) 0.91
Effect of 15-lipoxygenase metabolites on angiogenesis: 15(S)-HPETE is angiostatic and 15(S)-HETE is angiogenic. Inflamm Res (2012) 0.88
Regulation of endothelial cell functions by basement membrane- and arachidonic acid-derived products. Wiley Interdiscip Rev Syst Biol Med (2010) 0.88
Cyclooxygenase-2 up-regulates vascular endothelial growth factor via a protein kinase C pathway in non-small cell lung cancer. J Exp Clin Cancer Res (2011) 0.86
Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes Chromosomes Cancer (2013) 0.83
Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer. Exp Ther Med (2011) 0.83
Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination. Carcinogenesis (2013) 0.80
Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia. Prostaglandins Other Lipid Mediat (2013) 0.80
Non-synonymous polymorphism (Gln261Arg) of 12-lipoxygenase in colorectal and thyroid cancers. Fam Cancer (2012) 0.79
Evaluation of 12-lipoxygenase (12-LOX) and plasminogen activator inhibitor 1 (PAI-1) as prognostic markers in prostate cancer. Biomed Res Int (2014) 0.79
Enantio-alteration of gene transcription associated with bioconcentration in adult zebrafish (Danio rerio) exposed to chiral PCB149. Sci Rep (2016) 0.78
Regulation of vascular endothelial growth factor by metabolic context of the cell. Glycoconj J (2014) 0.78
Plasma Vasoprotective Eicosanoid Concentrations in Healthy Greyhounds and Non-Greyhound Dogs. J Vet Intern Med (2016) 0.76
A VE-cadherin-PAR3-α-catenin complex regulates the Golgi localization and activity of cytosolic phospholipase A(2)α in endothelial cells. Mol Biol Cell (2012) 0.76
Role of Modulator of Inflammation Cyclooxygenase-2 in Gammaherpesvirus Mediated Tumorigenesis. Front Microbiol (2017) 0.75
Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J (1992) 1.79
Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res (1995) 1.58
Prostacyclin: a potent antimetastatic agent. Science (1981) 1.58
Lysosomal cathepsin B: correlation with metastatic potential. Science (1981) 1.43
Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Cancer Res (1998) 1.33
Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc Natl Acad Sci U S A (1996) 1.33
Morphological study of the interaction of intravascular tumor cells with endothelial cells and subendothelial matrix. Cancer Res (1988) 1.29
Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sci U S A (1986) 1.29
Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res (1982) 1.24
Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom. Mol Pharmacol (1984) 1.22
Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis. Biochem Pharmacol (1983) 1.21
Interactions of cancer cells with the microvasculature during metastasis. FASEB J (1988) 1.20
Cysteine proteinases and metastasis. Cancer Metastasis Rev (1984) 1.18
Prostaglandins and cancer: a review of tumor initiation through tumor metastasis. Prostaglandins (1981) 1.18
Role of eicosanoids in prostate cancer progression. Cancer Metastasis Rev (2001) 1.16
Fetal bovine serum: a multivariate standard. Proc Soc Exp Biol Med (1975) 1.15
Eicosanoid regulation of angiogenesis: role of endothelial arachidonate 12-lipoxygenase. Blood (2000) 1.13
Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res (1993) 1.13
Arrest and extravasation of B16 amelanotic melanoma in murine lungs. A light and electron microscopic study. Lab Invest (1985) 1.13
Thromboxane A(2) regulation of endothelial cell migration, angiogenesis, and tumor metastasis. Biochem Biophys Res Commun (2000) 1.12
Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis. Clin Exp Metastasis (1989) 1.12
Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. Cancer Res (1987) 1.11
Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. Cancer Res (1989) 1.08
Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C. Cell Regul (1991) 1.08
12-Lipoxygenase, 12(S)-HETE, and cancer metastasis. Ann N Y Acad Sci (1994) 1.04
Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res (1994) 1.03
12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. Biochem Biophys Res Commun (1995) 1.03
Degradation of laminin by human tumor cathepsin B. Clin Exp Metastasis (1989) 1.03
Thrombin increases the metastatic potential of tumor cells. Int J Cancer (1993) 1.02
Biosynthesis of 12(S)-hydroxyeicosatetraenoic acid by B16 amelanotic melanoma cells is a determinant of their metastatic potential. Lab Invest (1994) 1.01
12(S)-hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids. Proc Natl Acad Sci U S A (1995) 0.99
Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. Adv Exp Med Biol (1997) 0.99
Plasma membrane-associated cysteine proteinases in human and animal tumors. Exp Cell Biol (1987) 0.98
Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer. Oncogene (1995) 0.97
Expression, subcellular localization and putative function of platelet-type 12-lipoxygenase in human prostate cancer cell lines of different metastatic potential. Int J Cancer (2000) 0.96
12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha. J Natl Cancer Inst (1994) 0.95
The lipoxygenase metabolite, 12(S)-HETE, induces a protein kinase C-dependent cytoskeletal rearrangement and retraction of microvascular endothelial cells. Exp Cell Res (1993) 0.95
Solid tumor cells express functional "tethered ligand" thrombin receptor. Cancer Res (1995) 0.95
Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface. Thromb Res (1992) 0.94
Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE. Int J Cancer (1993) 0.94
Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer. Oncogene (1995) 0.93
Adhesion molecules and tumor metastasis: an update. Invasion Metastasis (1995) 0.92
Radiation-induced increase in expression of the alpha IIb beta 3 integrin in melanoma cells: effects on metastatic potential. Radiat Res (1992) 0.92
Identification of 12-lipoxygenase interaction with cellular proteins by yeast two-hybrid screening. Biochemistry (2000) 0.92
Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system. Clin Exp Metastasis (1986) 0.91
Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological origin. Int J Cancer (1997) 0.91
Role for cathepsin B and cystatins in tumor growth and progression. Biol Chem Hoppe Seyler (1990) 0.91
Role of tumor cell glycoproteins immunologically related to glycoproteins Ib and IIb/IIIa in tumor cell-platelet and tumor cell-matrix interactions. FASEB J (1988) 0.91
Transcriptional activation of endothelial cell integrin alpha v by protein kinase C activator 12(S)-HETE. J Cell Sci (1995) 0.90
Role of alphaII(b)beta3 integrin in prostate cancer metastasis. Prostate (1998) 0.90
Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis. Haemostasis (1988) 0.90
Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J Biol Chem (1993) 0.89
Eicosanoid activation of extracellular signal-regulated kinase1/2 in human epidermoid carcinoma cells. J Biol Chem (2000) 0.89
An in vivo study of the role of the tumor cell cytoskeleton in tumor cell-platelet-endothelial cell interactions. Cancer Res (1990) 0.88
Membrane-associated cathepsin L: a role in metastasis of melanomas. Biochem Biophys Res Commun (1989) 0.88
The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation. Biochem Biophys Res Commun (1987) 0.88
Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion. Cancer Res (1996) 0.88
Nafazatrom (Bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation. FEBS Lett (1982) 0.87
The beta4 integrin subunit rescues A431 cells from apoptosis through a PI3K/Akt kinase signaling pathway. Biochem Biophys Res Commun (1999) 0.87
Inhibition by dihydropyridine class calcium channel blockers of tumor cell-platelet-endothelial cell interactions in vitro and metastasis in vivo. Biochem Pharmacol (1985) 0.86
Activity and protein distribution of 12-lipoxygenase in HEL cells: induction of membrane-association by phorbol ester TPA, modulation of activity by glutathione and 13-HPODE, and Ca(2+)-dependent translocation to membranes. Prostaglandins (1993) 0.86
Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins. Biochem Biophys Res Commun (1985) 0.86
Identification of a novel truncated alphaIIb integrin. Cancer Res (1998) 0.86
Diagnostic and prognostic markers for human prostate cancer. Prostate (1997) 0.86
Cathepsin B to cysteine proteinase inhibitor balance in metastatic cell subpopulations isolated from murine tumors. Cancer Res (1990) 0.86
Enhanced levels of cathepsin B mRNA in murine tumors. FEBS Lett (1989) 0.85
12(S)-hydroxyeicosatetraenoic acid increases the actin microfilament content in B16a melanoma cells: a protein kinase-dependent process. Int J Cancer (1998) 0.85
Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: comparison with chemotherapeutic agents. Biochem Biophys Res Commun (1979) 0.84
Effects of prostacyclin on tumor cell-induced platelet aggregation. Cancer Res (1984) 0.84
Thromboxanes and prostacyclin: positive and negative modulators of tumor growth. Biochem Biophys Res Commun (1981) 0.84
Involvement of a cathepsin B-like cysteine proteinase in platelet aggregation induced by tumor cells and their shed membrane vesicles. Clin Exp Metastasis (1986) 0.84
The lipoxygenase metabolite 12(S)-HETE promotes alpha IIb beta 3 integrin-mediated tumor-cell spreading on fibronectin. Int J Cancer (1992) 0.83
12-Lipoxygenase in A431 cells: genetic identity, modulation of expression, and intracellular localization. Exp Cell Res (1996) 0.83
Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants. Cancer Res (1994) 0.83
Tumor cell-platelet interactions in vitro and their relationship to in vivo arrest of hematogenously circulating tumor cells. Clin Exp Metastasis (1987) 0.83
Human prostate carcinoma cells express functional alphaIIb(beta)3 integrin. Cancer Res (1996) 0.83
Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin. Science (1982) 0.83
12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC alpha. Adv Exp Med Biol (1997) 0.83
Inhibition of radiation-enhanced expression of integrin and metastatic potential in B16 melanoma cells by a lipoxygenase inhibitor. Radiat Res (1994) 0.83
Role of tumor cytoskeleton and membrane glycoprotein IRGpIIb/IIIa in platelet adhesion to tumor cell membrane and tumor cell-induced platelet aggregation. Cancer Res (1988) 0.83
12(S)-HETE-induced microvascular endothelial cell retraction results from PKC-dependent rearrangement of cytoskeletal elements and alpha V beta 3 integrins. Prostaglandins (1993) 0.83
The role of eicosanoids in tumor growth and metastasis. Ernst Schering Res Found Workshop (2000) 0.82
Increased expression of alpha IIb beta 3 integrin in subpopulations of murine melanoma cells with high lung-colonizing ability. Int J Cancer (1992) 0.82
Protein-kinase-C inhibitor calphostin C reduces B16 amelanotic melanoma cell adhesion to endothelium and lung colonization. Int J Cancer (1992) 0.82
Ectopic alphaIIbbeta3 integrin signaling involves 12-lipoxygenase- and PKC-mediated serine phosphorylation events in melanoma cells. Thromb Haemost (2001) 0.82
Radiosensitivity of human prostate cancer cells can be modulated by inhibition of 12-lipoxygenase. Cancer Lett (2013) 0.82
The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells. Int J Cancer (1991) 0.82
Protein kinase C-dependent effects of 12(S)-HETE on endothelial cell vitronectin receptor and fibronectin receptor. J Cell Biol (1993) 0.82
Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma. Biochim Biophys Acta (1989) 0.81
Biological properties of 12(S)-HETE in cancer metastasis. Adv Prostaglandin Thromboxane Leukot Res (1995) 0.81
Role of prostaglandins in aldosterone production by the human adrenal. Biochem Biophys Res Commun (1976) 0.81
Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study. Invasion Metastasis (1987) 0.81
12(S)-HETE promotes tumor-cell adhesion by increasing surface expression of alpha V beta 3 integrins on endothelial cells. Int J Cancer (1993) 0.81
Fatty acid modulation of tumor cell-platelet-vessel wall interaction. Cancer Metastasis Rev (1992) 0.81
Role of protein kinase C and phosphatases in 12(S)-HETE-induced tumor cell cytoskeletal reorganization. Adv Exp Med Biol (1997) 0.81
Cisplatin and nifedipine: synergistic cytotoxicity against murine solid tumors and their metastases. Cancer Lett (1986) 0.80
Identification of the alpha IIb beta 3 integrin in murine tumor cells. J Biol Chem (1992) 0.80
Suppression of W256 carcinosarcoma cell apoptosis by arachidonic acid and other polyunsaturated fatty acids. Int J Cancer (1997) 0.80
Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation. J Cancer Res Clin Oncol (1992) 0.80